Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA)

MLA

Dalifer Freites-Núñez, et al. “Efficacy, Safety and Cost-Effectiveness of a Web-Based Platform Delivering the Results of a Biomarker-Based Predictive Model of Biotherapy Response for Rheumatoid Arthritis Patients: A Protocol for a Randomized Multicenter Single-Blind Active Controlled Clinical Trial (PREDIRA).” Trials, vol. 21, no. 1, Aug. 2020, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13063-020-04683-7.

APA

Dalifer Freites-Núñez, Athan Baillet, Luis Rodriguez-Rodriguez, Minh Vu Chuong Nguyen, Isidoro Gonzalez, Jose Luis Pablos, Alejandro Balsa, Monica Vazquez, Philippe Gaudin, & Benjamín Fernandez-Gutierrez. (2020). Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA). Trials, 21(1), 1–15. https://doi.org/10.1186/s13063-020-04683-7

Chicago

Dalifer Freites-Núñez, Athan Baillet, Luis Rodriguez-Rodriguez, Minh Vu Chuong Nguyen, Isidoro Gonzalez, Jose Luis Pablos, Alejandro Balsa, Monica Vazquez, Philippe Gaudin, and Benjamín Fernandez-Gutierrez. 2020. “Efficacy, Safety and Cost-Effectiveness of a Web-Based Platform Delivering the Results of a Biomarker-Based Predictive Model of Biotherapy Response for Rheumatoid Arthritis Patients: A Protocol for a Randomized Multicenter Single-Blind Active Controlled Clinical Trial (PREDIRA).” Trials 21 (1): 1–15. doi:10.1186/s13063-020-04683-7.